Cargando…
Vildagliptin ameliorates biochemical, metabolic and fatty changes associated with non alcoholic fatty liver disease
OBJECTIVE: To determine the effect of Vildagliptin in non-alcoholic, fatty liver disease patients with dyslipidemia. METHODS: A randomized placebo controlled trial was conducted at outpatient clinic of Medical Unit-I of Sheikh Zayed Medical College/Hospital, Rahim Yar Khan, in which fifty eight pati...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216289/ https://www.ncbi.nlm.nih.gov/pubmed/28083033 http://dx.doi.org/10.12669/pjms.326.11133 |